These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [A preliminary study on the inhibitory action of target-primaqine on the exoerythrocytic forms of Plasmodium yoelii yoelii]. Song J, Wang X, Huang F, Feng C, Zhang Z, Huo Y, Pang Q. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):117-9. PubMed ID: 7554159 [Abstract] [Full Text] [Related]
7. In vitro metabolism of the antimalarial agent primaquine by mouse liver enzymes and identification of a methemoglobin-forming metabolite. Strother A, Allahyari R, Buchholz J, Fraser IM, Tilton BE. Drug Metab Dispos; 1984; 12(1):35-44. PubMed ID: 6141909 [Abstract] [Full Text] [Related]
11. In vitro and in vivo evaluation of a primaquine prodrug without red blood cell membrane destabilization property. Davanço MG, Campos ML, Nogueira MA, Campos SL, Marques RV, dos Santos JL, Chin CM, da Fonseca LM, Peccinini RG. Biopharm Drug Dispos; 2012 Nov 22; 33(8):437-45. PubMed ID: 22899089 [Abstract] [Full Text] [Related]
14. In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differences. Mehrotra N, Lal J, Puri SK, Madhusudanan KP, Gupta RC. Biopharm Drug Dispos; 2007 Jul 22; 28(5):209-27. PubMed ID: 17410524 [Abstract] [Full Text] [Related]